Parental and offspring contribution of genetic markers of adult blood pressure in early life: The FAMILY study

PLoS One. 2017 Oct 18;12(10):e0186218. doi: 10.1371/journal.pone.0186218. eCollection 2017.

Abstract

Previous genome wide association studies (GWAS) identified associations of multiple common variants with diastolic and systolic blood pressure traits in adults. However, the contribution of these loci to variations of blood pressure in early life is unclear. We assessed the child and parental contributions of 33 GWAS single-nucleotide polymorphisms (SNPs) for blood pressure in 1,525 participants (515 children, 406 mothers and 237 fathers) of the Family Atherosclerosis Monitoring In early life (FAMILY) study followed-up for 5 years. Two genotype scores for systolic (29 SNPs) and diastolic (24 SNPs) blood pressure were built. Linear mixed-effect regressions showed significant association between rs1378942 in CSK and systolic blood pressure (β = 0.98±0.46, P = 3.4×10-2). The child genotype scores for diastolic and systolic blood pressure were not associated in children. Nominally significant parental genetic effects were found between the SNPs rs11191548 (CYP17A1) (paternal, β = 2.78±1.49, P = 6.1×10-2 for SBP and β = 3.60±1.24, P = 3.7×10-3 for DBP), rs17367504 (MTHFR) (paternal, β = 2.42±0.93, P = 9.3×10-3 for SBP and β = 1.89±0.80, P = 1.8×10-2 for DBP and maternal, β = -1.32±0.60, P = 2.9×10-2 and β = -1.97±0.77, P = 1.0×10-2, for SBP and DBP respectively) and child blood pressure. Our study supports the view that adult GWAS loci have a limited impact on blood pressure during the five first years of life. The parental genetic effects observed on blood pressure in children may suggest epigenetic mechanisms in the transmission of the risk of hypertension. Further replication is needed to confirm our results.

MeSH terms

  • Adult
  • Blood Pressure / genetics*
  • CSK Tyrosine-Protein Kinase
  • Child, Preschool
  • Female
  • Genetic Markers
  • Genome-Wide Association Study
  • Humans
  • Hypertension / genetics*
  • Hypertension / physiopathology
  • Infant
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Steroid 17-alpha-Hydroxylase / genetics*
  • src-Family Kinases / genetics*

Substances

  • Genetic Markers
  • CYP17A1 protein, human
  • Steroid 17-alpha-Hydroxylase
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • CSK Tyrosine-Protein Kinase
  • src-Family Kinases
  • CSK protein, human

Grants and funding

The present study has been funded by the Heart and Stroke Foundation of Ontario (grant # NA 7293 “Early genetic origins of cardiovascular risk factors”). The FAMILY study was funded by the Hamilton Health Science Foundation, the Canadian Institutes of Health Research and by Heart & Stroke Foundation of Ontario as well as additional grants from the PHRI internal funds. D.M. is supported by a Canada Research Chair in Genetics of Obesity. S.R.P is supported by the Heart and Stroke Foundation of Ontario (grant # NA 7293). S.S.A. holds the Heart and Stroke Foundation of Ontario, Michael G. DeGroote endowed Chair in Population Health and a Canada Research Chair in Ethnicity and Cardiovascular Disease. S.D.M is supported by a Canadian Institutes of Health Research New Investigator Salary Award. K.M.M. was supported by the Heart & Stroke Foundation Career Fellowship in preventive cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.